SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital AdmissionPeter S. Hamblin, Leon A. Bach, Sonali Shah et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 122
Using electronic medical record data to assess chronic kidney disease, type 2 diabetes and cardiovascular disease testing, recognition and management as documented in Australian general practice: a cross-sectional analysisJulia Jones, Craig Nelson, Natalie Lumsden et al.|Family Medicine and Community Health|2022Cited by 10